The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis

Yamazaki, Yuichi; Kakizaki, Satoru; Horiguchi, Norio; Sohara, Naondo; Sato, Ken; Takagi, Hitoshi; Mori, Masatomo; Negishi, Masahiko
April 2007
Gut;Apr2007, Vol. 56 Issue 4, p565
Academic Journal
Background: Non-alcoholic fatty liver disease is a common liver injury, but the pathophysiological mechanisms leading to the development of non-alcoholic steatohepatitis (NASH) remain unclear. The pathological roles of the nuclear receptor constitutive androstane receptor (CAR), a key regulator of drug-metabolising enzymes, in the development of NASH were investigated. Methods and results: CAR+/+ and CAR-/- mice were given a methionine and choline-deficient (MCD) diet to establish a dietary model of NASH. Increases in serum alanine aminotransferase (ALT) and in infiltration of inflammatory cells were dominant in CAR+/+ mice at 8 weeks. There was no significant difference in the lipid concentration of the liver-namely, the first hit between CAR+/+ and CAR-/- mice. The index of lipid peroxidation increased in liver of the CAR+/+ mice, as demonstrated by 8-iso-prostaglandin F2α (F2-isoprostanes). Western blotting analysis showed that nuclear translocation of CAR occurred in CAR+/+ mice fed the MCD diet. As a result, the CAR activation caused the lipid peroxidation-namely, the second hit. The expressions of cytochrome P450 (CYP)2B10, 2C29, 3A11 all increased considerably in the CAR+/+ mice. Furthermore, α smooth muscle actin immunohistochemistry and Sirius red staining showed an increase in the degree of fibrosis in CAR+/+ mice fed the MCD diet at 16 weeks. The mRNA expressions of collagen α1(1) and the tissue inhibitor of metalloproteinase-1 were found to be elevated in CAR+/+ mice. Conclusion: CAR caused the worsening of the hepatic injury and fibrosis in the dietary model of NASH. Our results suggest that the CAR nuclear receptor may thus play a critical role in the pathogenesis of NASH.


Related Articles

  • Constitutive Androstane Receptor.  // Encyclopedic Reference of Molecular Pharmacology;2004, p263 

    A definition of the term "constitutive androstane receptor" is presented. It refers to a nuclear receptor which binds a variety of endogenous substances as well as xenobiotics. It forms heterodimers with the retinoid X receptor, RXR and induces the expression of a variety of enzymes and...

  • Prediction of Deleterious Functional Effects of Non-Synonymous Single Nucleotide Polymorphisms in Human Nuclear Receptor Genes Using a Bioinformatics Approach. Ya-He Liu; Chun Guang Li; Shu-Feng Zhou // Drug Metabolism Letters;Dec2009, Vol. 3 Issue 4, p242 

    The nuclear receptor (NR) superfamily represents an important group of regulating factors that control the expression of a number of target genes including those encoding important drug metabolizing enzymes and drug transporters. Single nucleotide polymorphism (SNP) is the most common mutation...

  • Nuclear Receptor Regulation of Drug-metabolizing P450 Enzymes. Waxman, David J. // Encyclopedic Reference of Molecular Pharmacology;2004, p677 

    This encyclopedia entry provides information on nuclear receptor regulation for drug-metabolizing P450 enzymes. When cellular or tissue levels of one or more cyctochrome P450 enzymes is increased in response to treatment with certain drugs, P450 induction happens. This results to an increase of...

  • CAR.  // Encyclopedic Reference of Molecular Pharmacology;2004, p218 

    The article presents an encyclopedia entry for the constitutive androstane receptor, a nuclear receptor that forms complexes with the retinoid X receptor.

  • Role of Class II Nuclear Receptors in Liver Carcinogenesis. Li, Guodong; Guo, Grace L. // Anti-Cancer Agents in Medicinal Chemistry;2011, Vol. 11 Issue 6, p529 

    Nuclear receptors (NRs) are ligand-activated transcription factors that are important to life by regulating a wide variety of physiological and pathological functions. There are three classes of NRs defined by ligands and heterodimer partners. The Class II NRs are involved in a broad range of...

  • New Insights on the Xenobiotic-Sensing Nuclear Receptors in Liver Diseases-- CAR and PXR—. Kakizaki, Satoru; Yamazaki, Yuichi; Takizawa, Daichi; Negishi, Masahiko // Current Drug Metabolism;Sep2008, Vol. 9 Issue 7, p614 

    The xenobiotic receptors CAR and PXR constitute two important members of the NR1I nuclear receptor family. They function as sensors of toxic byproducts derived from the endogenous metabolism and of exogenous chemicals, in order to enhance their elimination. They regulate numerous genes which are...

  • Functional constraints on the constitutive androstane receptor inferred from human sequence variation and cross-species comparisons. Thompson, Emma E.; Kuttab-Boulos, Hala; Krasowski, Matthew D.; Di Rienzo, Anna // Human Genomics;Sep2005, Vol. 2 Issue 3, p168 

    Members of the NR11 subfamily of nuclear receptors play a role in the transcriptional activation of genes involved in drug metabolism and transport. NR113, the constitutive androstane receptor (CAR), mediates the induction of several genes involved in drug response, including members of the...

  • Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo. Meyer zu Schwabedissen, H E; Oswald, S; Bresser, C; Nassif, A; Modess, C; Desta, Z; Ogburn, E T; Marinova, M; Lütjohann, D; Spielhagen, C; Nauck, M; Kroemer, H K; Siegmund, W // Clinical Pharmacology & Therapeutics;Jul2012, Vol. 92 Issue 1, p103 

    Nuclear receptors such as the constitutive androstane receptor (CAR) are central factors that link drug exposure to the activities of drug metabolism and elimination. In order to determine the in vivo effects of efavirenz, a CAR activator, the expression of target genes was determined in...

  • Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Wang, Hongbing; LeCluyse, Edward L. // Clinical Pharmacokinetics;Dec2003, Vol. 42 Issue 15, p1331 

    During the past several years, important advances have been made in our understanding of the mechanisms that regulate the expression of genes that determine drug clearance, including phase I and phase II drug-metabolising enzymes and drug transporters. Orphan nuclear receptors have been...


Read the Article


Sign out of this library

Other Topics